[Elsevier] Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review

devroops Post time 2024-6-4 15:21:18 | Show all posts |Read mode
Reward10points

title: Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic reviewAuthors: Alessandro Mantovani, Christopher D Byrne, Giovanni Targher


Lancet Gastroenterol Hepatol . 2022 Apr;7(4):367-378.





Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
bitzkyboy Post time 2024-6-4 15:21:19 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    50

Latest Reply

Return to the list